These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31552833)

  • 21. Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells.
    Lucchetti D; Calapà F; Palmieri V; Fanali C; Carbone F; Papa A; De Maria R; De Spirito M; Sgambato A
    Am J Pathol; 2017 Jul; 187(7):1633-1647. PubMed ID: 28619275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
    Lee MR; Ji SY; Mia-Jan K; Cho MY
    Biochem Biophys Res Commun; 2015 Jul; 463(3):229-34. PubMed ID: 26002465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
    Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
    Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells.
    Wang XK; Zhou FF; Tao HR; Wang X; Zhang C; Su F; Wang SP; Xu LH; Pan XK; Feng MH; Xie W
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):880-885. PubMed ID: 29270747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.
    Fathi A; Mosaad H; Hussein S; Roshdy M; Ismail EI
    IUBMB Life; 2017 May; 69(5):328-340. PubMed ID: 28261953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM; Li XF; Liu H; Wu XL
    Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.
    Deng Y; Su Q; Mo J; Fu X; Zhang Y; Lin EH
    Cancer Invest; 2013 Feb; 31(2):97-102. PubMed ID: 23245395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Wu S; Wu F; Jiang Z
    Int J Oncol; 2018 Jun; 52(6):2093-2100. PubMed ID: 29620285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133: An emerging prognostic factor and therapeutic target in colorectal cancer.
    Akbari M; Shomali N; Faraji A; Shanehbandi D; Asadi M; Mokhtarzadeh A; Shabani A; Baradaran B
    Cell Biol Int; 2020 Feb; 44(2):368-380. PubMed ID: 31579983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-III CD133(+) cells of human gastric cancer].
    Wang SL; Yu JW; Cai C; Lu RQ; Wu JG; Ni XC; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):889-94. PubMed ID: 24062002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
    Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
    J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [microRNA-140 suppresses the migration and invasion of colorectal cancer cells through targeting Smad3].
    Zhao W; Zou J; Wang B; Fan P; Mao J; Li J; Liu H; Xiao J; Ma W; Wang M; Li L; Song B
    Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):739-45. PubMed ID: 25567303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
    Mo S; Ku HJ; Choi SH; Jeong HJ; Park DG; Oh MH; Ahn JC
    Anticancer Res; 2021 Mar; 41(3):1407-1420. PubMed ID: 33788732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
    Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.